A carregar...
New approaches to symptomatic treatments for Alzheimer’s disease
BACKGROUND: Successful development of agents that improve cognition and behavior in Alzheimer’s disease (AD) is critical to improving the lives of patients manifesting the symptoms of this progressive disorder. DISCUSSION: There have been no recent approvals of cognitive enhancing agents for AD. The...
Na minha lista:
| Publicado no: | Mol Neurodegener |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7805095/ https://ncbi.nlm.nih.gov/pubmed/33441154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-021-00424-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|